Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac-Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study

Abstract

Real-world data on heterologous boosting with messenger RNA (mRNA)-1273 (Moderna) after inactivated COVID-19 vaccination are limited. We report mRNA-1273 boosting in heavily SARS-CoV-2–exposed Indonesian health-care workers who received a two-dose CoronaVac 6 months prior. Between August and November 2021, we measured SARS-CoV-2 spike-specific IgG binding antibody (Bab) titers in all 304 participants, and neutralizing antibody titers in a random subset of 71 participants, on stored paired serum samples taken before and 28 days after a full-dose (100-μg) mRNA-1273 booster. At the time of the mRNA-1273 boost, 107 participants (35.2%) were not previously infected (naive vaccinated), 42 (13.8%) were infected before CoronaVac (infected vaccinated), and 155 (51.0%) were infected after CoronaVac (mostly during the Delta wave; vaccinated infected). At time of the mRNA-1273 boost, neutralizing antibodies could still be detected in 83% of participants (59 of 71) overall, 60% of naive-vaccinated participants (15 of 25), 95.7% of vaccinated-infected participants (22 of 23), and 95.7% of infected vaccinated participants (22 of 23). After the mRNA-1273 boost, 100% of participants (71 of 71) had neutralizing antibody activity, with increases in median Bab and neutralizing antibody serum titers of 9.3- and 27.0-fold overall, 89.1- and 2,803.4-fold in naive-vaccinated participants, 15.9- and 19.9-fold in infected-vaccinated participants, and 2.2- and 18.4-fold in vaccinated-infected participants. In the multivariable analysis, Bab titers after the mRNA-1273 boost were greatest in individuals who had a previous virus breakthrough post-CoronaVac, and when a longer time period (> 4 months) had elapsed since the most recent prior “spike antigen exposure” (either second CoronaVac or virus breakthrough). Overall, adverse reactions were mild and short-lived. In conclusion, a full-dose mRNA-1273 booster after CoronaVac was well tolerated and immunogenic after 28 days, including in those with very low antibody levels.

Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia

“…Thereby, it is recommended and safe to administer a heterologous booster vaccine, especially using mRNA vaccines, such as Moderna and Pfizer ( Goh et al, 2022 ). Similar to this study, investigations on Indonesian healthcare workers receiving two-dose CoronaVac and one dose of Moderna booster also showed 100% anti-SARS-CoV-2 antibodies positivity ( Cucunawangsih et al, 2022 ; Hidayat et al, 2022 ; Sinto et al, 2023 ).…”

Geographical variations and district-level factors associated with COVID-19 mortality in Indonesia: a nationwide ecological study

“…Nonetheless, our study suggests that a higher mortality rate was associated with a lower number of nurses per population. In Indonesia, the lack of healthcare workers, combined with the high number of infections [ 40 ] and deaths among health care workers and doctors [ 41 ], especially during the early phase of the epidemic, had weakened the health system resilience. A recent review of Indonesian healthcare system suggested that the currently available medical staffs are insufficient to deal with the pandemic, and that the referral system in Indonesia has been hampered by a shortage of specialists and poorly equipped referral facilities, as well as weak coordination, even before the pandemic [ 42 ].…”

Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide analysis of programme data and health system vulnerabilities

“…Several additional factors, which our analysis was not able to capture, may have further exacerbated the pandemic impacts on TB case finding and diagnostic and treatment services. First, high rates of infection 32 as well as deaths 33 among frontline health care workers resulted in substantial absenteeism and task-shifting, especially during the early pandemic. Notably, a recent report estimated that Indonesian healthcare workers had a five times higher chance of death from COVID-19 than the general population.…”